Vaxxas attracts US$20m series B finance to develop needle-free vaccine delivery

Vaxxas, a UniQuest start-up company commercialising the novel Nanopatch™…


UniQuest and AstraZeneca in drug repositioning open innovation collaboration

Pharmaceutical company AstraZeneca and UniQuest have formed an “open…


UniQuest collaboration with Janssen targets therapies for ankylosing spondylitis

On 11 June 2015, UniQuest announced that it entered into an R&D and license…


UQ commits to QEDDI drug discovery initiative driven by UniQuest

The University of Queensland has made a commitment to the discovery and…


Dendright announces early clinical trial success for new rheumatoid arthritis treatment

Dendright Pty Ltd, a UniQuest biopharmaceutical company developing novel…


Professor Ian Frazer and Admedus Vaccines - working to transform global health issues

Since 2000 a University of Queensland (UQ) spin off company, Admedus Vaccines…


Multi-million dollar deal brings UQ pain drug closer to reality

A chronic pain treatment discovered at The University of Queensland is a step…


UQ and UniQuest launch small molecule drug discovery and development initiative

The Queensland Government has provided in-principle support for a new…


UniQuest congratulates Professor Ian Frazer on winning international Inventor Award

UniQuest congratulates The University of Queensland’s Professor Ian…